statistiche ricercatore

Continente	#
AS - Asia	937
NA - Nord America	884
EU - Europa	628
SA - Sud America	235
Continente sconosciuto - Info sul continente non disponibili	17
AF - Africa	11
OC - Oceania	2
Totale	2.714

Nazione	#
US - Stati Uniti d'America	813
SG - Singapore	341
CN - Cina	222
IT - Italia	221
BR - Brasile	177
RU - Federazione Russa	156
VN - Vietnam	129
BD - Bangladesh	79
GB - Regno Unito	47
HK - Hong Kong	46
CA - Canada	42
DE - Germania	41
FR - Francia	37
FI - Finlandia	30
IN - India	27
SE - Svezia	21
MX - Messico	20
PL - Polonia	20
AR - Argentina	17
ID - Indonesia	17
TR - Turchia	17
EC - Ecuador	14
NL - Olanda	13
IQ - Iraq	10
JP - Giappone	10
AT - Austria	9
CO - Colombia	9
ES - Italia	9
PK - Pakistan	7
PE - Perù	6
IL - Israele	5
PY - Paraguay	5
UA - Ucraina	5
VE - Venezuela	5
JO - Giordania	4
LT - Lituania	4
MY - Malesia	4
UZ - Uzbekistan	4
CH - Svizzera	3
BY - Bielorussia	2
CI - Costa d'Avorio	2
CL - Cile	2
DO - Repubblica Dominicana	2
GR - Grecia	2
KE - Kenya	2
KZ - Kazakistan	2
MA - Marocco	2
SA - Arabia Saudita	2
AE - Emirati Arabi Uniti	1
AF - Afghanistan, Repubblica islamica di	1
AL - Albania	1
AU - Australia	1
AZ - Azerbaigian	1
BA - Bosnia-Erzegovina	1
BB - Barbados	1
CG - Congo	1
CR - Costa Rica	1
CU - Cuba	1
CZ - Repubblica Ceca	1
DK - Danimarca	1
EG - Egitto	1
GE - Georgia	1
IE - Irlanda	1
JM - Giamaica	1
LB - Libano	1
LV - Lettonia	1
NC - Nuova Caledonia	1
NI - Nicaragua	1
NP - Nepal	1
OM - Oman	1
PH - Filippine	1
PS - Palestinian Territory	1
SI - Slovenia	1
SK - Slovacchia (Repubblica Slovacca)	1
SN - Senegal	1
SV - El Salvador	1
TH - Thailandia	1
TN - Tunisia	1
TT - Trinidad e Tobago	1
TW - Taiwan	1
ZA - Sudafrica	1
Totale	2.697

Nome	#
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosis	315
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study	263
Role of Imaging in Cardiomyopathies	239
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis	239
Cardiac amyloidosis characterization by kinetic model fitting on [18F]florbetaben PET images	230
The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis	219
Tissue Characterization in Cardiac Amyloidosis	214
Positron emission tomography in cardiac amyloidosis: current evidence and future directions	206
PET and Cardiac Amyloidosis	200
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis	192
Automated Neural Architecture Search for Cardiac Amyloidosis Classification from [18F]-Florbetaben PET Images	188
Diagnosis and Prognostication With PET Imaging: The (Next) Future in Light Chain Amyloidosis	168
Diagnosis and Prognostication With PET Imaging: The (Next) Future in Light Chain Amyloidosis	41
Totale	2.714

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2022/2023	12	0	0	0	0	5	0	0	3	2	2	0	0
2023/2024	77	3	0	13	18	4	7	11	1	0	1	3	16
2024/2025	484	8	11	27	6	23	21	59	81	37	17	78	116
2025/2026	2.085	142	288	212	303	196	153	152	106	149	132	157	95
2026/2027	56	48	8	0	0	0	0	0	0	0	0	0	0
Totale													2.714